DA
KERX

David Abrams’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

David Abrams’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,108,867
Closed -$31M – 22
2018
Q3 		$31M Sell
9,108,867
-841,188
-8% -$3.03M 0.82% 19
2018
Q2 		$37.4M Buy
9,950,055
+230,879
+2% +$1.12M 1.04% 18
2018
Q1 		$39.8M Hold
9,719,176
– – 1.25% 17
2017
Q4 		$45.2M Buy
9,719,176
+4,000,000
+70% +$22M 1.52% 16
2017
Q3 		$40.6M Hold
5,719,176
– – 1.58% 14
2017
Q2 		$41.4M Hold
5,719,176
– – 1.64% 15
2017
Q1 		$35.2M Hold
5,719,176
– – 1.35% 15
2016
Q4 		$33.5M Hold
5,719,176
– – 1.23% 16
2016
Q3 		$30.4M Hold
5,719,176
– – 1.51% 15
2016
Q2 		$37.9M Hold
5,719,176
– – 1.98% 11
2016
Q1 		$26.7M Buy
5,719,176
+219,176
+4% +$875K 1.26% 16
2015
Q4 		$27.8M Buy
5,500,000
+500,000
+10% +$2.38M 1.52% 15
2015
Q3 		$17.6M Buy
+5,000,000
New +$33.5M 1.26% 14

David Abrams's KERX Position: Q4 2018 in Review

David Abrams sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 9,108,867 shares — an estimated $31M sold.

David Abrams first reported a position in KERX in Q3 2015 and held it in 13 quarters. The position peaked at $45.2M in Q4 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • David Abrams reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • David Abrams sold 9,108,867 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $31M.
  • David Abrams first reported a position in Keryx Biopharmaceuticals Inc in Q3 2015 and held it in 13 quarters.
  • David Abrams's Keryx Biopharmaceuticals Inc position peaked at $45.2M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Abrams Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.